A controversy has erupted in Nigeria over the sale to a foreign company of the rights to a patent on a locally developed drug for sickle cell anaemia. The drug, NIPRISAN, was developed by a traditional medicine practitioner working in collaboration with researchers at Nigeria’s National Institute for Pharmaceutical Research Development (NIPRD) in Abuja.